Methodology
How the Desk Score is assigned
Every provider receives a Desk Score from 0 to 100 across six weighted dimensions, then a letter grade. The same rubric runs against every provider — 6 factors, one formula, no exceptions. Here is exactly what we measure and how much each dimension counts.
Price transparency
25%Whether the provider publishes all-in monthly pricing up front — sticker price, intro vs. renewal rate, and any step-up. Opaque or drip-reveal pricing costs significant points.
State access
20%How many U.S. states the provider actively serves, and whether that coverage is disclosed clearly. 'All 50' with proof outscores 'multi-state' with no published list.
Molecule range
18%Breadth of GLP-1 molecules offered (semaglutide, tirzepatide), plus route options — injection, oral, and sublingual — and titration flexibility.
Onboarding speed
15%Time from first inquiry to first prescription: intake form length, async vs. synchronous consultation model, and pharmacy turnaround signals.
Support responsiveness
12%Availability and quality of clinical follow-up, side-effect escalation pathways, and patient-support access (async messaging, phone, pharmacy liaison).
Licensing & trust
10%Provider verification confidence: prescriber licensing signals, pharmacy accreditation disclosures, and compounding-regulatory compliance posture.
The grade scale
A (93+), A− (90–92), B+ (87–89), B (83–86), B− (80–82), C+ (77–79), C (below 77). A grade is a relative read on today's market, not a safety rating or a medical endorsement.
What the Desk Score never reflects
Affiliate relationships. A provider that pays us a referral commission runs through the identical rubric as one that doesn't. A weak provider scores low regardless. What a partnership can affect is promotional emphasis — a featured placement, a highlighted dispatch — and that emphasis is always labeled. The number is never for sale. See our disclosure.
Provider facts come from each provider's public disclosures and the WLR provider matrix at the time of scoring; they change often. This is consumer research, not medical advice.